Obstructive Sleep Apnea
Among patients with obstructive sleep apnea, older age and reduced BMI are predictors of upper airway stimulation treatment response.
Solriamfetol therapy, compared with placebo, results in improvements in wakefulness and sleepiness measures in patients with excessive sleepiness due to obstructive sleep apnea.
A team of authors performed a systematic review of studies examining anti-inflammatory treatments for pediatric OSA through June 28, 2018 using PubMed/MEDLINE and 4 other databases.
For individuals with obstructive sleep apnea, those with short respiratory event duration have an increased risk for mortality.
The investigators found a significant reduction in the mean preimplantation apnea-hypopnea index at 6 months after hypoglossal nerve stimulation.
Primary care management of obstructive sleep apnea is as effective and more cost-effective than in-laboratory diagnosis.
Research was conducted to identify an association between the use of serotonin reuptake inhibitors and obstructive sleep apnea in a population of individuals with depression with or without epilepsy.
Female OSA patients had multiple regions of reduced cortical thickness in superior frontal lobe.
The FDA has accepted the New Drug Application for solriamfetol for the treatment of sleep disorders.
Male gender, excessive daytime sleepiness, and presence of metabolic syndrome were among the risk factors for obstructive sleep apnea in major depression.
CPAP therapy shows to reduce PTSD symptoms in veterans with PTSD and OSA.
Obstructive sleep apnea and intermittent hypoxia may be mechanisms that are associated with marker of increased amyloid burden.
Treatment with positive airway pressure may help retain or improve seizure control in patients with epilepsy and obstructive sleep apnea.
Home sleep apnea tests are designed to help diagnose OSA in adults.
Patients with multiple sclerosis who experience severe fatigue should be screened for obstructive sleep apnea.
The risk of bone health decline in menopausal women is reduced with intermittent hypoxia in OSA.
Older adults with sleep-disordered breathing have a 26% greater risk for developing cognitive impairment and a small risk for deteriorating executive function.
Obstructive sleep apnea is associated with elevated blood coagulability.
There may be a relationship between sleep disordered breathing and Alzheimer's disease caused by biological changes in the brain.
Risks of adverse cardiovascular-related outcomes or mortality are not reduced with CPAP treatment.
Patients with sleep apnea are more likely to use their CPAP after watching themselves struggle with breathing at night.
Obstructive sleep apnea in patients with type 2 diabetes is a predictor for diabetic retinopathy.
Hematocrit levels and presence of erythrocytosis were associated with awake and nocturnal hypoxemia, according to the study.
A significant association was found between the apnea-hypopnea index and Epworth Sleepiness Scale scores.
The guideline contains updated recommendations from previous practice parameters and guidelines published in 2005 and 2007.
Reduced REM sleep was correlated with a 23% increased risk of atrial fibrillation, while insomnia was associated with a 29% increased risk.
Patients with obstructive sleep apnea have a more difficult time keeping their lane while driving.
A study was performed to identify the underlying mechanisms by which patients with obstructive sleep apnea (OSA) gain weight after initiating continuous positive airway pressure (CPAP) treatment.
After 6 months, the CPAP group saw a greater decrease in HbA1c levels compared to controls.
Only 42% with diagnoses OSA report adherence to CPAP treatment.
Neurology Advisor Articles
- Case Study Report: Herbal Supplement Kratom Associated With Neonatal Abstinence Syndrome
- Serum Vitamin D Levels and Risk for Migraine
- Mobile Health Apps for Headache: An Ongoing Search for Clinical Relevancy
- Seizure Monitoring Smartwatch Cleared for Use in Children
- Researchers ID Factors Predictive of Naming Decline After Epilepsy Surgery
- Very Early Mobilization After Stroke Does Not Improve Survival Over Usual Care
- Alemtuzumab Linked to Clinical and MRI Disease Remission in Multiple Sclerosis
- Cognitive Decline Worsens With Memantine, ChEIs in Patients With Alzheimer's
- Cervical Dysfunction Needs Clarification to Identify Link With Headache
- Levodopa Inhalation Powder Approved for Parkinson Disease
- Supine Positioning After Greater Occipital Nerve Block May Improve Outcomes
- Resting-State MEG May Indicate MS-Related Cognitive Decline
- Odor Discrimination and Identification Linked to Neurodegeneration in MS
- American College of Physicians Releases 7th Edition of Ethics Manual
- Obesity Linked to Lower Gray Matter Brain Volume